Vanda Pharmaceuticals
VNDA
#8812
Rank
ยฃ0.15 B
Marketcap
ยฃ2.63
Share price
-6.13%
Change (1 day)
-28.16%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): -ยฃ3.46

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ3.53. In 2025 the company made an earnings per share (EPS) of -ยฃ2.85 a decrease over its 2024 EPS that were of -ยฃ0.24.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ3.4621.27%
2025-ยฃ2.851065.63%
2024-ยฃ0.24-710.9%
2023ยฃ0.04004-56.35%
2022ยฃ0.09173-80%
2021ยฃ0.46
2019ยฃ1.66334%
2018ยฃ0.38-247.06%
2017-ยฃ0.26-19.05%
2016-ยฃ0.32-55.32%
2015-ยฃ0.72-347.37%
2014ยฃ0.29-156.72%
2013-ยฃ0.51-31.63%
2012-ยฃ0.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.11-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ4.01-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.54-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.61-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.76-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.46-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ3.36-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA